Health

Artificial intelligence (AI) is being rapidly adopted throughout the healthcare industry as organizations make more substantial investments in their AI infrastructure, the number of tech-forward pilot programs continues to grow, …

AbbVie is boosting its already strong presence in immunology with the acquisition of Apogee Therapeutics, a clinical-stage biotech whose most advanced drug candidate could bring advantages over several currently available …

A simmering dispute between Eli Lilly and the nation’s hospitals boiled over last week. The drugmaker had been threatening to pull 340B discounts from hospitals that refused to submit claims …

At a time where vaccine skepticism is growing and the childhood vaccine schedule updated in January, vaccine manufacturers are running into a difficult regulatory review process in the United States. …

For decades, employer-sponsored healthcare relied on the same predictable levers to manage spending. Employers rolled out higher deductibles, narrower networks, and increased cost sharing. But a more meaningful shift is …

The case that many startups are making for automating the healthcare revenue cycle is pretty straightforward. Claims follow rules, payers adhere to guidelines, and most of this work is repetitive …

For both the builders and users of clinical AI, bias remains one of the single greatest issues keeping the industry up at night. The prevailing anxiety revolves around one urgent …

America funds the crisis. It’s time to fund the care that prevents it. The post Dying Without a Safety Net appeared first on MedCity News. Staff Reporter

In January 2026, CMS launched the Wasteful and Inappropriate Service Reduction (WISeR) model, introducing prior authorization into traditional Medicare for certain services in selected states. However, this controversial program could …

An Eli Lilly drug bringing a new approach to blood cancers now has encouraging early data from a small clinical study showing reductions in signs and symptoms of disease, results …